title: Acute liver injury related to the use of niperotidine.
abstract: OBJECTIVE
  H2-receptor antagonists are widely used for the therapy of peptic disease, since they ensure a protracted and intense inhibition of gastric acidity. Niperotidine (piperonyl-ranitidine) is a new H2 blocking agent recently proposed for clinical use.
  
  
  METHODS
  Twenty-five cases of acute hepatitis associated with the use of niperotidine were reported in Italy between March and August 1995. Intercurrent viral infections, recent drug and alcohol consumption and blood transfusions were excluded as causes.
  
  
  RESULTS
  All patients showed an increase in the parameters of liver cell injury and the clinical symptoms of acute hepatitis. After withdrawal of the drug, all patients showed a good outcome, except one who developed a fulminant hepatitis and died from digestive tract bleeding.
  
  
  CONCLUSIONS
  The absence of other causes of acute liver injury suggests that the observed liver injury may be a niperotidine-adverse reaction. Moreover, the lack of a relationship between the dose of the drug and the degree of liver damage, the variable latent period and the rarity and unpredictability of the injury are suggestive of an idiosyncratic reaction.
authors.affiliation: Istituto di Medicina Interna, Università Cattolica, Rome, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Gasbarrini
authors.forename: N
authors.initials: N
authors.lastname: Gentiloni
authors.forename: S
authors.initials: S
authors.lastname: Febbraro
authors.forename: A
authors.initials: A
authors.lastname: Gasbarrini
authors.forename: C
authors.initials: C
authors.lastname: Di Campli
authors.forename: M
authors.initials: M
authors.lastname: Cesana
authors.forename: F
authors.initials: F
authors.lastname: Miglio
authors.forename: M
authors.initials: M
authors.lastname: Miglioli
authors.forename: F
authors.initials: F
authors.lastname: Ghinelli
authors.forename: A
authors.initials: A
authors.lastname: D'Ambrosi
authors.forename: P
authors.initials: P
authors.lastname: Amoroso
authors.forename: F
authors.initials: F
authors.lastname: Pacini
authors.forename: G
authors.initials: G
authors.lastname: Salvadori
mesh_terms: D000208:Acute Disease; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000410:Alanine Transaminase / Q000378:metabolism; D000469:Alkaline Phosphatase / Q000378:metabolism; D001219:Aspartate Aminotransferases / Q000378:metabolism; D001663:Bilirubin / Q000378:metabolism; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D004149:Dioxoles / Q000009:adverse effects*; D005260:Female; D005663:Furans / Q000009:adverse effects*; D006635:Histamine H2 Antagonists / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies
chemical_list: D004149:Dioxoles; D005663:Furans; D006635:Histamine H2 Antagonists; C073716:niperotidine; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase; D001663:Bilirubin